Polterauer Stephan, Schwameis Richard, Grimm Christoph, Macuks Ronalds, Iacoponi Sara, Zalewski Kamil, Zapardiel Ignacio
Department of General Gynaecology and Gynaecological Oncology, Gynecologic Cancer Unit - Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria; Karl Landsteiner Institute for General Gynecology and Experimental Gynecologic Oncology, Vienna, 1090, Austria.
Department of General Gynaecology and Gynaecological Oncology, Gynecologic Cancer Unit - Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.
Gynecol Oncol. 2017 Oct;147(1):92-97. doi: 10.1016/j.ygyno.2017.07.142. Epub 2017 Aug 7.
To estimate the prognostic significance of lymph node ratio and number of positive nodes in vulvar cancer patients.
This international multicenter retrospective study included patients diagnosed with vulvar cancer treated with inguinal lymphadenectomy. Lymph node ratio (LNR) is the ratio of the number of positive lymph nodes (LN) to the number of removed LN. Patients were stratified into risk groups according to LNR. LNR was correlated with clinical-pathological parameters. Survival analyses were performed.
This analysis included 745 patients. In total, 292 (39.2%) patients had positive inguinal LN. The mean (SD) number of resected and positive LN was 14.1 (7.6) and 3.0 (2.9), respectively. High LNR was associated with larger tumor size and higher tumor grade. Patients with LNRs 0% (N0), >0<20%, and >20% had 5-year overall survival (OS) rates of 90.9%, 70.7%, and 61.8%, respectively (P<0.001). LNR was associated with both local and distant recurrence-free survival (P<0.001). Patients with 0, 1, 2, 3 or >3 positive lymph nodes had 5-year OS rates of 90.9%, 70.8%, 67.8%, 70.8% and 63.4% respectively (P<0.001). In multivariate analysis, LNR (P=0.01) and FIGO stage (P<0.001), were associated with OS, whereas the number of positive nodes (P=0.8), age (P=0.2), and tumor grade (P=0.7), were not. In high-risk patients, adjuvant radiotherapy was associated with improved survival.
LNR provides useful prognostic information in vulvar cancer patients with inguinal LN resection in vulvar cancer. LNR allows for more accurate prognostic stratification of patients than number of positive nodes. LNR seems useful to select appropriate candidates for adjuvant radiation.
评估外阴癌患者淋巴结比率及阳性淋巴结数量的预后意义。
这项国际多中心回顾性研究纳入了接受腹股沟淋巴结清扫术治疗的外阴癌患者。淋巴结比率(LNR)是阳性淋巴结数量与切除淋巴结数量之比。根据LNR将患者分层为风险组。LNR与临床病理参数相关。进行生存分析。
该分析纳入745例患者。总计292例(39.2%)患者腹股沟淋巴结阳性。切除淋巴结及阳性淋巴结的平均(标准差)数量分别为14.1(7.6)和3.0(2.9)。高LNR与更大肿瘤大小及更高肿瘤分级相关。LNR为0%(N0)、>0<20%和>20%的患者5年总生存率(OS)分别为90.9%、70.7%和61.8%(P<0.001)。LNR与局部及远处无复发生存均相关(P<0.001)。阳性淋巴结数量为0、1、2、3或>3个的患者5年OS率分别为90.9%、70.8%、67.8%、70.8%和63.4%(P<0.001)。多因素分析中,LNR(P=0.01)和国际妇产科联盟(FIGO)分期(P<0.001)与OS相关,而阳性淋巴结数量(P=0.8)、年龄(P=0.2)和肿瘤分级(P=0.7)则无关。在高危患者中,辅助放疗与生存改善相关。
LNR为接受腹股沟淋巴结切除的外阴癌患者提供了有用的预后信息。与阳性淋巴结数量相比,LNR能更准确地对患者进行预后分层。LNR似乎有助于选择合适的辅助放疗候选者。